医学
急性呼吸窘迫综合征
吸入氧分数
低氧血症
重症监护室
麻醉
重症监护
队列
重症监护医学
队列研究
观察研究
急诊医学
机械通风
肺
内科学
作者
Rolf Erlebach,Una Pale,T. Beck,Saša Marković,Marko Seric,Sascha David,E. Keller
出处
期刊:Critical Care
[BioMed Central]
日期:2025-02-19
卷期号:29 (1): 82-82
被引量:6
标识
DOI:10.1186/s13054-025-05317-7
摘要
Abstract Background The ratio of pulse-oximetric peripheral oxygen saturation to fraction of inspired oxygen (SpO 2 /FiO 2 ) has been proposed as additional hypoxemia criterion in a new global definition of acute respiratory distress syndrome (ARDS). This study aims to evaluate the clinical and theoretical limitations of the SpO 2 /FiO 2 -ratio when using it to classify patients with ARDS and to follow disease progression. Methods Observational cohort study of ARDS patients from three high-resolution Intensive Care Unit databases, including our own database ICU Cockpit, MIMIC-IV (Version 3.0) and SICdb (Version 1.0.6). Patients with ARDS were identified based on the Berlin criteria or ICD 9/10-codes. Time-matched datapoints of SpO 2 , FiO 2 and partial pressure of oxygen in arterial blood (PaO 2 ) were created. Severity classification followed the thresholds for SpO 2 /FiO 2 and PaO 2 /FiO 2 of the newly proposed global definition. Results Overall, 708 ARDS patients were included in the analysis. ARDS severity was misclassified by SpO 2 /FiO 2 in 33% of datapoints, out of which 84% were classified as more severe. This can be partially explained by imprecision of SpO 2 measurement and equation used to transform SpO 2 /FiO 2 to PaO 2 /FiO 2. A high dependence of SpO 2 /FiO 2 -ratio on FiO 2 settings was found, leading to major treatment effect and limited capability for tracking change in ARDS severity, which was achieved in less than 20% of events. Conclusions The use of SpO 2 /FiO 2 interchangeably with PaO 2 /FiO 2 for severity classification and monitoring of ARDS is limited by its inadequate trending ability and high dependence on FiO 2 settings, which may influence treatment decisions and patient selection in clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI